Benefit-risk balance for marketed drugs : evaluating safety signals : report of CIOMS Working Group IV.
Material type: TextPublication details: Geneva : CIOMS, 1998. Description: 160 pISBN: 9290360682Subject(s): Drug evaluation | Risk assessment -- methods -- standards | Safety management | Decision support techniques | Adverse drug reaction reporting systems -- standards | Case-control studies | Models, Theoretical | Pharmaceuticals and BiologicalsNLM classification: WB 330 98COItem type | Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Books | WHO HQ READING-RM | WB 330 98CO (Browse shelf(Opens below)) | 1 | Available | 00061149 | |
Books | WHO HQ BORROWABLE-COLL-STACKS | WB 330 98CO (Browse shelf(Opens below)) | 2 | Available | 00061150 |
Browsing WHO HQ shelves, Shelving location: BORROWABLE-COLL-STACKS Close shelf browser (Hides shelf browser)
No cover image available | ||||||||
WB 330 97PL The Placebo effect : | WB 330 97SH The powerful placebo : | WB 330 97ST Cost-sharing and pharmaceutical utilisation in Russia : | WB 330 98CO Benefit-risk balance for marketed drugs : | WB 330 99AS An Assessment of US pharmaceutical donations : | WB 340 95US Use medication wisely : | WB 342 82HI Aerosol technology : |
DC.CIOMS
eng.
WHODOC
WHO monograph
4
There are no comments on this title.